series-b
Stage
1
Investors
About
Entrada Therapeutics develops intracellular therapeutics using its proprietary Endosomal Escape Vehicle platform to deliver molecules such as RNA, antibodies, and enzymes for treating serious diseases including Duchenne Muscular Dystrophy.
Explore Entrada Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.